RPT-J&J's Stelara shows promise against lupus in study - Reuters

FiercePharma

RPT-J&J's Stelara shows promise against lupus in study Reuters Nov 4 (Reuters) - Johnson & Johnson's blockbuster psoriasis drug Stelara led to a significant reduction in disease activity in patients with systemic lupus compared with a placebo in a midstage clinical trial, according to data released on Saturday ... STELARA® (ustekinumab) Shows Positive Results In Treatment Of Systemic Lupus Erythematosus In Phase 2 TrialPR Newswire (press release) Janssen's (JNJ) STELARA Shows Positive Results in Treatment of Systemic Lupus Erythematosus in Phase 2 TrialStreetInsider.com Lupus Research Alliance Prompted Stelara® Study for Lupus - Results Show Potential for New Treatment OptionMarkets Insider FiercePharma all 9 news articles »

from Health - Google News http://ift.tt/2zhUItq